Product Images Bicillin L-a

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Bicillin L-a NDC 60793-701 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chem structure - bicillin 01

Chem structure - bicillin 01

Logo - bicillin 02

Logo - bicillin 02

This is a description of a product called "Injectables" which is distributed by Pfizer Inc, located in New York, NY 10017.*

PRINCIPAL DISPLAY PANEL - 1 mL Syringe Label - bicillin 03

PRINCIPAL DISPLAY PANEL - 1 mL Syringe Label - bicillin 03

Bicillin L-A is an injectable suspension with 600,000 units of penicillin G benzathine per 1 mL. It is indicated for deep intramuscular injection only, and it should not be given by alternative routes as it can be fatal. The product is distributed by a company based in New York with the NDC number 60703-700-01.*

PRINCIPAL DISPLAY PANEL - 1 mL Syringe Carton - bicillin 04

PRINCIPAL DISPLAY PANEL - 1 mL Syringe Carton - bicillin 04

This is a description of a box of Bicillin L-A, a penicillin G benzathine injectable suspension used for pediatric use. The package contains ten syringes of 1 L size, providing 600,000 units per 1 mL. It is to be used for deep intramuscular injection only. There is a warning on the package about the fatal consequences if given by other routes and instructions to be followed before injecting, which can be found on the package insert. The package needs to be kept refrigerated at 2-8°C, and exchange is possible if needed.*

PRINCIPAL DISPLAY PANEL - 2 mL Syringe Label - bicillin 05

PRINCIPAL DISPLAY PANEL - 2 mL Syringe Label - bicillin 05

This is the label of Bicillin L-A, an injection suspension containing penicillin G benzathine which is used for deep intramuscular injection only. The label includes information about dosage and distribution warnings. The product is distributed by a company located in New York.*

PRINCIPAL DISPLAY PANEL - 2 mL Syringe Carton - bicillin 06

PRINCIPAL DISPLAY PANEL - 2 mL Syringe Carton - bicillin 06

Bicillin L-A is an injectable suspension of penicillin G benzathine with 1,200,000 units per 2 mL for deep intramuscular injection only. It comes in ten syringes of 2 mL size. It is important to see the package insert for administration instructions before injecting. Fatal if given by other routes. Store in a refrigerator at 2-8°C (36-45°F). Dosage information is not available.*

PRINCIPAL DISPLAY PANEL - 4 mL Syringe Label - bicillin 07

PRINCIPAL DISPLAY PANEL - 4 mL Syringe Label - bicillin 07

BICILLIN L-A is an injectable suspension containing 2,400,000 units per 4 mL of penicillin G benzathine. This medication is for deep intramuscular injection only and should not be diluted or given by other routes. The National Drug Code for this product is 60793-702-04. There is also a warning that the medication can be fatal if given by other routes. The location of the company that produces this medication is in New York City.*

PRINCIPAL DISPLAY PANEL - 4 mL Syringe Carton - bicillin 08

PRINCIPAL DISPLAY PANEL - 4 mL Syringe Carton - bicillin 08

This appears to be a package insert for the medication Bicillin L-A, an injectable suspension containing penicillin G benzathine. It comes in a disposable syringe and is intended for intramuscular injection. The package contains 2,400,000 units per 4 mL. The insert warns that it is fatal if given by routes other than intramuscularly and provides specific administration instructions. There are also some numbers written on the insert, possibly for lot or batch tracking.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.